Hasil Pencarian - Cheng-Hao Chuang

  • Menampilkan 1 - 10 hasil dari 10
Perbaiki Hasil
  1. 1
    Combination of chemotherapy and immunotherapy may overcome the resistance to immunotherapy alone in pulmonary lymphoepithelial carcinoma

    Combination of chemotherapy and immunotherapy may overcome the resistance to immunotherapy alone in pulmonary lymphoepithelial carcinoma oleh Huei‐Yang Hung, Wei‐An Lai, Cheng‐Hao Chuang, Chih‐Jen Yang

    Diterbitkan 2024-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Therapeutic plasma exchange for refractory vaccine‐induced immune thrombotic thrombocytopenia

    Therapeutic plasma exchange for refractory vaccine‐induced immune thrombotic thrombocytopenia oleh Sheng‐Bin Fan, Ming‐Ju Tsai, Mei‐Chuan Kuo, Cheng‐Hao Chuang

    Diterbitkan 2022-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Emergent bronchoscopic cryotherapy may safely cease invasive lung cancer induced massive endobronchial hemorrhaging in patients with high oxygen supply

    Emergent bronchoscopic cryotherapy may safely cease invasive lung cancer induced massive endobronchial hemorrhaging in patients with high oxygen supply oleh Feng‐Ching Shen, Cheng‐Hao Chuang, Ying‐Ming Tsai, Chih‐Jen Yang

    Diterbitkan 2021-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Oxidation Behavior Characterization of Zircaloy-4 Cladding with Different Hydrogen Concentrations at 500–800 °C in an Ambient Atmosphere

    Oxidation Behavior Characterization of Zircaloy-4 Cladding with Different Hydrogen Concentrations at 500–800 °C in an Ambient Atmosphere oleh Tung-Yuan Yung, Wen-Fang Lu, Kun-Chao Tsai, Cheng-Hao Chuang, Po-Tuan Chen

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    FAK Executes Anti-Senescence via Regulating EZH2 Signaling in Non-Small Cell Lung Cancer Cells

    FAK Executes Anti-Senescence via Regulating EZH2 Signaling in Non-Small Cell Lung Cancer Cells oleh Hsiang-Hao Chuang, Ming-Shyan Huang, Yen-Yi Zhen, Cheng-Hao Chuang, Ying-Ray Lee, Michael Hsiao, Chih-Jen Yang

    Diterbitkan 2022-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Targeting Pin1 for Modulation of Cell Motility and Cancer Therapy

    Targeting Pin1 for Modulation of Cell Motility and Cancer Therapy oleh Hsiang-Hao Chuang, Yen-Yi Zhen, Yu-Chen Tsai, Cheng-Hao Chuang, Ming-Shyan Huang, Michael Hsiao, Chih-Jen Yang

    Diterbitkan 2021-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    FAK in Cancer: From Mechanisms to Therapeutic Strategies

    FAK in Cancer: From Mechanisms to Therapeutic Strategies oleh Hsiang-Hao Chuang, Yen-Yi Zhen, Yu-Chen Tsai, Cheng-Hao Chuang, Michael Hsiao, Ming-Shyan Huang, Chih-Jen Yang

    Diterbitkan 2022-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Cysteinyl Leukotriene Pathway and Cancer

    Cysteinyl Leukotriene Pathway and Cancer oleh Ming-Ju Tsai, Wei-An Chang, Cheng-Hao Chuang, Kuan-Li Wu, Chih-Hung Cheng, Chau-Chyun Sheu, Ya-Ling Hsu, Jen-Yu Hung

    Diterbitkan 2021-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Operando X-ray and Mass Spectroscopy of Reduced Graphene Oxide (rGO)-Mediated Cobalt Catalysts for Boosting the Hydrogen Evolution Reaction

    Operando X-ray and Mass Spectroscopy of Reduced Graphene Oxide (rGO)-Mediated Cobalt Catalysts for Boosting the Hydrogen Evolution Reaction oleh Carl Osby M. Mariano, Russell Hizon Clemente, Meng-Hsuan Tsai, Yi-Ying Chin, Jin-Ming Chen, Jyh-Fu Lee, Ying-Jui Lu, Chien-Ming Chen, Po-Tuan Chen, Cheng-Hao Chuang

    Diterbitkan 2024-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Clinical outcome of bevacizumab or ramucirumab combined with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors as the first line therapy in susceptible EGFR‐mutated advanced non‐small‐cell lung

    Clinical outcome of bevacizumab or ramucirumab combined with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors as the first line therapy in susceptible EGFR‐mutate... oleh Chia‐Yu Kuo, Ming‐Ju Tsai, Jen‐Yu Hung, Mei‐Hsuan Lee, Kuan‐Li Wu, Yu‐Chen Tsai, Cheng‐Hao Chuang, Chung‐Wen Huang, Chin‐Ling Chen, Chih‐Jen Yang, Inn‐Wen Chong

    Diterbitkan 2024-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: